EUVIMEDEUVIMED entdecken
Crossref

Neutropenia in myelosuppressed cancer patients treated with recombinant human erythropoietin (EPO)

Daniel G. Wright, Elizabeth C. Wright, Constance T. Noguchi

Journal of Clinical and Experimental Hematology · 2026

DOI: 10.46439/hematol.5.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematology, 2026. Verfasst von Daniel G. Wright und 2 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant human erythropoietin (EPO) has been used extensively for over 3 decades to treat anemia, including that associated with cancer treatment. Multiple randomized clinical trials have found that EPO treatment ameliorates anemia and reduces transfusion requirements in cancer patients undergoing chemotherapy. However, reports of some trials suggested that EPO treatment might also exacerbate neutropenia, as anticipated by pre-clinical observations that EPO suppresses neutrophil production in short- and long-term marrow cultures. However, neutropenia was expected in these trials and not reported in detail. Recently, primary data from 5 industry-sponsored trials of EPO treatment in cancer patients became available through the Yale Open Data Access (YODA) project, allowing us to examine serial absolute neutrophil counts (ANCs) from 1650 cancer patients randomized to EPO or placebo treatment. The incidence of severe neutropenia (ANCs

Zitieren

APA

Wright, D. G., Wright, E. C., & Noguchi, C. T. (2026). Neutropenia in myelosuppressed cancer patients treated with recombinant human erythropoietin (EPO). Journal of Clinical and Experimental Hematology. https://doi.org/10.46439/hematol.5.034

Vancouver

Wright DG, Wright EC, Noguchi CT. Neutropenia in myelosuppressed cancer patients treated with recombinant human erythropoietin (EPO). Journal of Clinical and Experimental Hematology. 2026. doi:10.46439/hematol.5.034

BibTeX
@article{Wright2026,
  author = {Wright, Daniel G. and Wright, Elizabeth C. and Noguchi, Constance T.},
  title = {Neutropenia in myelosuppressed cancer patients treated with recombinant human erythropoietin (EPO)},
  journal = {Journal of Clinical and Experimental Hematology},
  year = {2026},
  doi = {10.46439/hematol.5.034}
}
Kostenlos starten →